158 related articles for article (PubMed ID: 33965490)
41. Improvement of the Antioxidant and Antitumor Activities of Benzimidazole-Chitosan Quaternary Ammonium Salt on Drug Delivery Nanogels.
Ma B; Li Q; Zhang J; Mi Y; Tan W; Guo Z
Mar Drugs; 2024 Jan; 22(1):. PubMed ID: 38248665
[TBL] [Abstract][Full Text] [Related]
42. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
[TBL] [Abstract][Full Text] [Related]
43. CD44-targeted nanoparticles with GSH-responsive activity as powerful therapeutic agents against breast cancer.
Brindisi M; Curcio M; Frattaruolo L; Cirillo G; Leggio A; Rago V; Nicoletta FP; Cappello AR; Iemma F
Int J Biol Macromol; 2022 Nov; 221():1491-1503. PubMed ID: 36130642
[TBL] [Abstract][Full Text] [Related]
44. Folic Acid-Modified Nanoerythrocyte for Codelivery of Paclitaxel and Tariquidar to Overcome Breast Cancer Multidrug Resistance.
Zhong P; Chen X; Guo R; Chen X; Chen Z; Wei C; Li Y; Wang W; Zhou Y; Qin L
Mol Pharm; 2020 Apr; 17(4):1114-1126. PubMed ID: 32176509
[TBL] [Abstract][Full Text] [Related]
45. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
46. Programmed pH/reduction-responsive nanoparticles for efficient delivery of antitumor agents in vivo.
Chen WL; Yang SD; Li F; Qu CX; Liu Y; Wang Y; Wang DD; Zhang XN
Acta Biomater; 2018 Nov; 81():219-230. PubMed ID: 30267887
[TBL] [Abstract][Full Text] [Related]
47. Stimuli-responsive hybrid cluster bombs of PEGylated chitosan encapsulated DOX-loaded superparamagnetic nanoparticles enabling tumor-specific disassembly for on-demand drug delivery and enhanced MR imaging.
Xie P; Du P; Li J; Liu P
Carbohydr Polym; 2019 Feb; 205():377-384. PubMed ID: 30446118
[TBL] [Abstract][Full Text] [Related]
48. A reversible, switchable pH-driven quaternary ammonium pillar[5]arene nanogate for mesoporous silica nanoparticles.
Santos ECS; Dos Santos TC; Fernandes TS; Jorge FL; Nascimento V; Madriaga VGC; Cordeiro PS; Checca NR; Da Costa NM; Pinto LFR; Ronconi CM
J Mater Chem B; 2020 Jan; 8(4):703-714. PubMed ID: 31867589
[TBL] [Abstract][Full Text] [Related]
49. Robust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materials.
Sun B; Deng C; Meng F; Zhang J; Zhong Z
Acta Biomater; 2016 Nov; 45():223-233. PubMed ID: 27576338
[TBL] [Abstract][Full Text] [Related]
50. Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells.
Roy K; Patel YS; Kanwar RK; Rajkhowa R; Wang X; Kanwar JR
Int J Nanomedicine; 2016; 11():25-44. PubMed ID: 26730188
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and evaluation of pH-sensitive, self-assembled chitosan-based nanoparticles as efficient doxorubicin carriers.
Raja MA; Arif M; Feng C; Zeenat S; Liu CG
J Biomater Appl; 2017 Mar; 31(8):1182-1195. PubMed ID: 28081668
[TBL] [Abstract][Full Text] [Related]
52. Targeted Smart pH and Thermoresponsive N,O-Carboxymethyl Chitosan Conjugated Nanogels for Enhanced Therapeutic Efficacy of Doxorubicin in MCF-7 Breast Cancer Cells.
Verma NK; Purohit MP; Equbal D; Dhiman N; Singh A; Kar AK; Shankar J; Tehlan S; Patnaik S
Bioconjug Chem; 2016 Nov; 27(11):2605-2619. PubMed ID: 27643823
[TBL] [Abstract][Full Text] [Related]
53. pH-triggered intracellular release of doxorubicin by a poly(glycidyl methacrylate)-based double-shell magnetic nanocarrier.
Zohreh N; Rastegaran Z; Hosseini SH; Akhlaghi M; Istrate C; Busuioc C
Mater Sci Eng C Mater Biol Appl; 2021 Jan; 118():111498. PubMed ID: 33255062
[TBL] [Abstract][Full Text] [Related]
54. Reduction/pH dual-sensitive PEGylated hyaluronan nanoparticles for targeted doxorubicin delivery.
Xu M; Qian J; Suo A; Wang H; Yong X; Liu X; Liu R
Carbohydr Polym; 2013 Oct; 98(1):181-8. PubMed ID: 23987334
[TBL] [Abstract][Full Text] [Related]
55. Core-Shell Silver/Polymeric Nanoparticles-Based Combinatorial Therapy against Breast Cancer In-vitro.
Elbaz NM; Ziko L; Siam R; Mamdouh W
Sci Rep; 2016 Aug; 6():30729. PubMed ID: 27491622
[TBL] [Abstract][Full Text] [Related]
56. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
[TBL] [Abstract][Full Text] [Related]
57. Endosomal pH-Responsive Fe-Based Hyaluronate Nanoparticles for Doxorubicin Delivery.
Bae Y; Kim Y; Lee ES
Molecules; 2021 Jun; 26(12):. PubMed ID: 34200716
[TBL] [Abstract][Full Text] [Related]
58. Tumor-targeting and pH-responsive nanoparticles from hyaluronic acid for the enhanced delivery of doxorubicin.
Liao J; Zheng H; Fei Z; Lu B; Zheng H; Li D; Xiong X; Yi Y
Int J Biol Macromol; 2018 Jul; 113():737-747. PubMed ID: 29505869
[TBL] [Abstract][Full Text] [Related]
59. Dual-pH responsive chitosan nanoparticles for improving in vivo drugs delivery and chemoresistance in breast cancer.
Chen Q; Jia C; Xu Y; Jiang Z; Hu T; Li C; Cheng X
Carbohydr Polym; 2022 Aug; 290():119518. PubMed ID: 35550759
[TBL] [Abstract][Full Text] [Related]
60. Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells.
Wang H; Agarwal P; Zhao S; Xu RX; Yu J; Lu X; He X
Biomaterials; 2015 Dec; 72():74-89. PubMed ID: 26344365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
